Competency category
Setting Management
Preparing and managing the physical and sensory environment across preparation, dosing, and integration.
94 competencies, 43 with this as their primary category.
Looking for something specific? Ask Blossom
Primary competencies (43)
Competencies whose primary home is this category.
Mindfulness, intention-setting, set and setting, and somatic presence
PrimaryTeaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.
7 care stages · 9 guidelines · 7 courses · 6 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreEnsure confidentiality and session containment
PrimaryMaintain a contained therapeutic environment that protects the patient’s privacy and minimizes unwanted exposure. The session structure emphasizes confidentiality and controlled access to stimulation and outside contact.
6 care stages · 9 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreClient preparation and therapeutic set/setting
PrimaryCluster covering 2 related competencies including: Preparation of set and setting, Client preparation and therapeutic set/setting.
6 care stages · 8 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetamineLSD+2 moreSafe Therapeutic Container Creation
PrimaryTeaches providers to create and maintain a psychologically and physically safe therapeutic setting through clear structure, preparation, boundaries, attunement, environmental design, and ongoing attention to participant safety.
5 care stages · 6 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreSafe treatment-setting facilitation
PrimaryProvide a calm and supportive environment during treatment to reduce distress and support tolerance of the experience. The case report notes food, rest, and a quiet place as part of care.
6 care stages · 6 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMescalineMusic and therapist-variable awareness
PrimaryThe course explicitly mentions the role of music and therapist variables in treatment. Learners are expected to understand how these elements influence the PAP experience and therapeutic outcome.
5 care stages · 4 guidelines · 1 courses · 1 providers
KetamineMDMANonintrusive session monitoring and containment
PrimaryFacilitators must balance active safety monitoring with minimal interference in the participant’s inner experience. The role includes maintaining continuous presence, periodic check-ins, and preserving the therapeutic container of the session.
4 care stages · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMA+1 morePre-session dosing behavior instructions
PrimaryTeaches clear communication of behavioral requirements before dosing sessions so conditions are standardized and preventable risks are reduced. Staff confirm that participants understand and follow pre-session instructions.
4 care stages · 4 guidelines · 0 courses · 0 providers
KetaminePsilocybinAttendant supervision and role clarity
PrimaryTherapists must ensure attendants are appropriately selected and instructed for overnight monitoring. Attendants provide supportive care and observation without taking on psychotherapeutic functions.
3 care stages · 3 guidelines · 0 courses · 0 providers
MDMASetting optimization
PrimaryCreate an environment that supports safety, comfort, and relaxation during the session. The setting is deliberately structured to reduce anxiety and facilitate a positive experience.
5 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaineVirtual care facilitation
PrimaryCapacity to conduct assessments and therapy sessions virtually when needed while preserving safety and confidentiality. The study permits telehealth sessions for certain visits and contingencies.
4 care stages · 3 guidelines · 0 courses · 0 providers
KetaminePsilocybinDosing-day facilitation
PrimaryCluster covering 2 related competencies including: Dosing-day facilitation, Dosing-session facilitation.
4 care stages · 2 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinCeremonial framing and intentional therapeutic setting
PrimaryFacilitators require skill in establishing ceremonial and intentional framing around ketamine sessions to support therapeutic depth and coherence. This includes preparing participants for the significance and structure of the experience within the group model.
3 care stages · 2 guidelines · 0 courses · 0 providers
KetamineConfidential and nonjudgmental therapeutic stance
PrimaryFacilitators should create a safe interpersonal environment conducive to disclosure and processing. The setting is intentionally designed to support openness, comfort, and trust.
3 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinGroup facilitation and relationship management
PrimaryWhen leading group sessions, therapists must manage group size, relational instability, empathic bonds, exclusion dynamics, and mutual support among therapists. The handbook treats group structure as a clinically important variable.
2 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDNighttime and overnight participant support
PrimaryWhen overnight stays are required, facilitators and attendants must maintain safe observation and supportive presence without acting as outside therapists. They need to monitor comfort, safety, and emergency access overnight.
4 care stages · 2 guidelines · 0 courses · 0 providers
MDMASession pacing and timing
PrimaryTherapists must pace the day appropriately, from early dosing to flexible termination, avoiding premature ending that could destabilize the subject. The handbook presents timing as an active facilitative skill rather than a logistical detail.
2 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDWork within medically supervised settings
PrimaryLSD-assisted psychotherapy in this study is explicitly framed as medically supervised. Therapists/facilitators need to practice within a setting capable of medical oversight and management of prolonged altered states.
2 care stages · 2 guidelines · 0 courses · 0 providers
IbogaineLSDContextualization and ceremony design
PrimaryFacilitators may use ritual, music, prayer, altar work, or minimalist approaches to frame the experience. Whatever the style, they should use contextualization intentionally and in service of the participant’s process.
3 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTDocumentation of subjective experience
PrimaryThe therapist/facilitator must record participant-reported effects and clinically relevant observations accurately. Documentation supports both safety monitoring and outcome interpretation.
3 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaDyadic facilitation and gender-balanced therapeutic presence
PrimaryExperimental sessions are conducted by a male physician-investigator and an experienced female nurse, indicating competency in co-therapy, complementary roles, and continuous therapeutic presence.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAGroup facilitation and relational process leadership
PrimaryTherapists and facilitators must be able to guide intentional group process in a way that supports safety, connection, and meaningful change. This includes managing both large- and small-group formats and maintaining a relationally anchored therapeutic environment.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineIndividual versus group modality selection
PrimaryTherapists should understand the distinct advantages, limitations, and indications of individual and group methods. Clinical judgment is required to choose format, order, staffing, and group composition.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDKnowledge of psychedelic session structure
PrimaryFacilitators need to understand the full treatment sequence and how each phase contributes to safety and treatment delivery. The intervention depends on correct sequencing and timing.
6 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinLSD psychotherapy administration
PrimaryAbility to administer LSD in a psychotherapy setting using the regimen described in the source. The therapist/facilitator must understand session-based dosing and treatment course structure.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDManaging short-duration high-intensity sessions
Primary5-MeO-DMT produces a very short but intense experience, which changes facilitation demands. Facilitators must be prepared for rapid transitions into and out of the altered state.
5 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMusic selection and management
PrimaryUse music intentionally as part of the therapeutic environment and processing sequence. Music should support, not direct, the patient’s unfolding internal experience.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMARecognition of contextual limitations
PrimaryThe facilitator should understand that effects observed in a controlled clinical setting may differ from those in ceremonial or ritual contexts. This awareness shapes interpretation and informs safer translation to other settings.
2 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaResidential addiction treatment facilitation
PrimaryAble to function within an inpatient rehabilitation setting for substance-related disorders. The facilitator must support the structured residential environment and care of patients with addiction comorbidity.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaShort-duration session management
PrimaryThe facilitator should be able to manage a brief but intense treatment window. The source suggests a shorter-acting psychedelic may enable rapid onset of response and reduce burden compared with longer-acting agents.
3 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTStructure a therapeutic learning environment
PrimaryThe therapist’s core role is to structure conditions that maximize the subject’s opportunity for self-understanding and change, tailored to the subject, therapist, and relevant environmental variables. The handbook repeatedly frames therapeutic effectiveness as depending on how well the clinician shapes the setting and process rather than directing content for the patient.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDSupportive context design
PrimaryThe article indicates that a structured, supportive context is associated with more positive acute and enduring effects and fewer challenging experiences. Facilitators should actively design the session context around safety and support.
2 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTTherapeutic use of equipment and stimuli
PrimaryThe handbook describes skillful use of music, images, mirrors, and simple comforts to guide attention, reduce distress, and deepen self-examination. These supports are not incidental but part of the structured method.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDUse and training of overnight attendants
PrimaryFacilitators must coordinate appropriate overnight support personnel and ensure they are trained for the role. Attention to participant comfort and boundaries is built into staffing decisions.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAUse of music, chant, sound, and aroma
PrimaryFacilitators may use sound and scent intentionally to support launch, peak, and re-entry, but these modalities must never become distracting. They need judgment about timing, dosage, and participant responsiveness.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTWork collaboratively in therapist dyads and supervised teams
PrimaryPsilocybin sessions are conducted with two trained therapists, and therapists-in-training may support sessions under supervision. Effective dyad work and supervised learning are central to the model.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinDosing-session framework
PrimaryCluster covering 2 related competencies including: Dosing-session framework, Dosing-session framework use.
3 care stages · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinApprenticeship and mentor shadowing
PrimaryThe program includes supervised apprenticeship hours with pre-approved mentors. Learners are expected to observe, assist, and translate training into supervised practice.
6 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinHuman-centred, experiential facilitation
PrimaryThe overall program emphasizes experiential, relational, and community-grounded learning, including retreat and practicum components. Learners are expected to develop a grounded facilitation presence in addition to theory.
4 care stages · 0 guidelines · 1 courses · 1 providers
MDMAPsilocybinRitual closing and cleansing
PrimaryThe training includes practices for cleansing and closing psychedelic sessions appropriately. This signals competence in ending sessions in a structured, culturally responsive way.
3 care stages · 0 guidelines · 1 courses · 1 providers
KetamineSpace preparation and ceremonial setup
PrimaryPracticum hours may include operational tasks like preparing rooms, setting up altars, and arranging ceremonial spaces. These are treated as part of hands-on professional competence.
3 care stages · 0 guidelines · 1 courses · 1 providers
Hybrid in-person and virtual session support
PrimaryThe course teaches students to guide both in-person and online sessions, including the technical skills needed for virtual facilitation. It explicitly notes that online training includes learning tech skills to become a confident virtual guide.
4 care stages · 0 guidelines · 0 courses · 1 providers
PsilocybinKetamineDMT / Ayahuasca+1 moreVirtual safety and support management
PrimaryThe program states that the virtual training has been streamlined so students feel safe and supported no matter what arises. This signals competency in maintaining safety in online psychedelic support contexts.
3 care stages · 0 guidelines · 0 courses · 1 providers
Also mapped here (51)
Competencies that touch this category as a secondary axis.
Discharge readiness, escort safety, and post-session supervision
Teaches how to determine when a participant is safe to leave after dosing and how to arrange appropriate supervision afterward. The competency covers psychological and physical stability, escort/support-person coordination, discharge restrictions, overnight or post-session support, and follow-up contact when needed.
8 care stages · 30 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 morePhysical safety monitoring
Cluster covering 3 related competencies including: Physical safety monitoring, Safety monitoring during dosing sessions, Medical safety monitoring during psilocybin administration.
6 care stages · 19 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreSupportive nondirective therapeutic stance
Cluster covering 6 related competencies including: Therapeutic support during dosing, Nondirective dosing-session presence, Supportive dosing-session facilitation.
7 care stages · 16 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 morePsilocybin session facilitation
Cluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.
8 care stages · 14 guidelines · 6 courses · 5 providers
LSDPsilocybinPhysiologic monitoring, thermoregulation, hydration, and overdose response
Teaches monitoring and response for acute physiological risks, including vital signs, temperature, hydration, overheating, excessive fluid intake, and suspected overdose. The competency emphasizes supportive care, medical coordination, documentation, and escalation when needed.
5 care stages · 11 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreTrauma-informed therapeutic presence and somatic support
Teaches a trauma-informed stance during psychedelic work, including calm presence, non-verbal reassurance, body-aware support, somatic orientation, and containment through difficult experiences while maintaining safety and boundaries.
6 care stages · 9 guidelines · 2 courses · 2 providers
KetamineMDMAPsilocybinPhysiologic monitoring during ketamine administration
Cluster covering 2 related competencies including: Safety monitoring during ketamine dosing, Physiologic monitoring during ketamine administration.
6 care stages · 8 guidelines · 0 courses · 0 providers
KetaminePsychedelic-assisted therapy facilitation
Cluster covering 2 related competencies including: Psychedelic-assisted therapy facilitation, Group facilitation in a psychedelic setting.
6 care stages · 8 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineLSD+2 morePsychological support during altered states
Provides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.
7 care stages · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreVital sign and physical distress monitoring
Monitors participant physical status during study visits and identifies concerning changes requiring escalation. Vital signs and symptomatic changes are part of routine safety observation.
6 care stages · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 morePsilocybin psychotherapy framework
Cluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.
8 care stages · 5 guidelines · 4 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinSession facilitation and therapeutic holding
Cluster covering 2 related competencies including: Session facilitation and therapeutic holding, Session facilitation and support during intense experiences.
5 care stages · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreMatch dose and setting to patient capacity
Therapists/facilitators need judgment about dosing and setting so experiences remain tolerable and therapeutically useful. The paper repeatedly notes that when dose and setting are appropriate, emerging material remains within the patient’s capacity to cope.
3 care stages · 5 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSD+2 moreProvide overnight and next-day containment
Therapists must ensure continuity of care after the acute session, including overnight observation and next-morning integration before discharge. This reflects a containment and recovery responsibility beyond the dosing period.
5 care stages · 5 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSD+2 moreRisk evaluation and safety monitoring
Teaches continuous evaluation of clinical risk and maintenance of a safe care environment throughout preparation, dosing, and follow-up. Learners monitor risk signals, apply safety procedures, and escalate care when needed.
8 care stages · 4 guidelines · 3 courses · 2 providers
5-MeO-DMTIbogaineKetamine+2 moreTherapeutic touch judgment
The training includes appropriate use of therapeutic touch as part of safe delivery. Learners are expected to use touch judiciously and within ethical boundaries.
5 care stages · 4 guidelines · 1 courses · 1 providers
MDMADosage judgment and administration safety
Competent facilitation requires practical knowledge of dosage ranges, initial dosing, boosters, formulation handling, and administration errors. The handbook stresses both clinical judgment and meticulous procedural care.
3 care stages · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreManage agitation and elopement risk
Respond to agitation or attempts to leave the room in a way that preserves safety for the patient and others. The therapist should use containment, redirection, and escalation protocols when needed.
4 care stages · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMDMA+1 moreBalance inner focus with communication
Therapists should support an appropriate rhythm between inward experiential focus and verbal interaction, with either therapist or participant able to initiate shifts.
3 care stages · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMASupport peak or mystical-type experiences without imposing them
Facilitators should be able to contain and make therapeutic use of profound emotional or peak experiences, including ego loosening, awe, reassurance, and feelings of unity or peace. The article suggests these experiences can be highly meaningful and therapeutic, but not all need to meet full mystical criteria.
3 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineLSDSupport safe administration of LSD dosing sessions
Because the protocol involved specific LSD doses, active placebo control, and session spacing, facilitators need applied skill in implementing dosing-session procedures safely and consistently. This includes maintaining therapeutic support while adhering to protocol constraints.
4 care stages · 3 guidelines · 0 courses · 0 providers
LSDMescalineTherapeutic alliance and trust building
The therapist must create an atmosphere of confidence and mutual understanding before ketamine administration. This relationship is treated as a key therapeutic factor in the protocol.
5 care stages · 3 guidelines · 0 courses · 0 providers
IbogaineKetaminePsilocybinUnderstanding of trial procedures and schedule
Know the sequence, timing, and purpose of screening, preparation, dosing, scanning, follow-up, and unblinding visits. The therapist/facilitator must be able to work within the full protocol structure.
6 care stages · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinCompetence in protocol adherence for dosing sessions
The intervention involved two separate psilocybin dosing sessions 3 weeks apart under a randomized controlled protocol, implying the need for facilitators to reliably support treatment according to a fixed schedule and study procedures.
4 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinNon-directive facilitation
Therapists must facilitate rather than control the participant's process, using invitations and timing interventions carefully. They should preserve the participant-led unfolding of experience while knowing when gentle direction or safety-based assertiveness is needed.
2 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAPreparation for altered-state experience
A major therapist competency is preparing patients extensively for the ketamine session, including the nature of the special state of consciousness and possible ego dissolution or separation from the body. Preparation is both educational and psychotherapeutic.
3 care stages · 2 guidelines · 0 courses · 0 providers
KetamineMDMAStress inoculation and breathwork instruction
At least one therapist must be able to teach stress inoculation methods, especially diaphragmatic breathing, and apply breath-based interventions during sessions. Breath is used both for relaxation and for staying present with difficult experience.
4 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAWork with bodily sensations and somatic process
Therapists should orient to and explore the participant’s somatic experience, both in experimental and integrative sessions, as a central channel of processing.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAWork with psychodynamic material
Therapists need knowledge of psychodynamic processes likely to arise under LSD, including emergence of previously excluded material, abreaction, catharsis, and memory-rich reliving of past experiences. The discussion explicitly identifies these as mechanisms relevant to treatment.
2 care stages · 2 guidelines · 0 courses · 0 providers
LSDPsychotherapeutic facilitation methods
Cluster covering 2 related competencies including: Facilitation of psychedelic journeys, Psychotherapeutic facilitation methods.
6 care stages · 1 guidelines · 2 courses · 2 providers
LSDPsilocybinAssessment-related participant support
Therapists and study staff must manage participant distress and fatigue associated with questionnaires and interviews. Competence includes pacing, offering breaks, and responding supportively to emotionally evocative content.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinCheck-in and timing of interventions during sessions
Therapists must skillfully time check-ins and interventions to sustain process without unnecessary intrusion. They monitor silence, talking, avoidance, and signs of internal engagement to decide when to inquire, redirect, or simply witness.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMAClinical experience for assistant facilitator
Assistant facilitators require practical clinical experience in a licensed healthcare setting. Their role supports safety, containment, and session logistics rather than independent psychotherapy practice.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineCoordination with backup facilitators and monitor
Facilitators must work in a structured team environment with a separate study monitor and backup facilitators. They need to respond rapidly when additional 1:1 support is required and accept direction from the lead facilitator and PI.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinCultural and ceremonial competence
Able to participate in or support ceremonial treatment elements respectfully and appropriately. The source indicates ceremonial behavior and traditional medicine are part of the intervention, requiring cultural competence and sensitivity.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaFocused bodywork competence
Focused bodywork is an optional advanced intervention used to facilitate release of blocked emotion or somatic tension when spontaneous processing has stalled. Therapists need specific judgment and skill to apply it safely and only when indicated.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAManage challenges with letting go and self-control
Therapists must help patients navigate early-session resistance, distrust, and discomfort related to surrendering usual control. Several participants reported temporary difficulty letting go or tolerating altered self-control.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDOvernight support role boundaries
Attendants and facilitators must maintain clear role boundaries, distinguishing supportive presence from psychotherapy or interpretation during overnight care.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAPre-onset psychological set management
Before symptoms begin, the therapist must prevent boredom, over-monitoring for effects, and escalating apprehension. This phase is treated as crucial because the psychological set established here shapes much of what follows.
2 care stages · 1 guidelines · 0 courses · 0 providers
LSDStructured smoking cessation treatment delivery
Facilitators must be able to deliver psilocybin only as an adjunct within a structured 15-week smoking cessation protocol rather than as a standalone intervention. This requires integrating psychedelic sessions with established tobacco cessation treatment methods.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinSupervised at-home treatment oversight
Ability to support supervised at-home ketamine use when clinically appropriate. This implies monitoring and structure even outside the office setting.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineSupport confrontation with existential anxiety
Therapists should be able to help patients face anxiety, fear of death, hopelessness, and suffering associated with life-threatening illness. The treatment context explicitly targets existential distress and uses LSD sessions to engage these themes.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDSupport emotional expression and catharsis
Therapists must be comfortable with powerful affect and able to support its expression without becoming reactive or controlling. Their role includes normalizing, containing, and encouraging tears, sounds, movement, and other forms of emotional release.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport positive and corrective emotional experiences
Therapists must also recognize and deepen beneficial states such as joy, self-affirmation, resolution, empathy, forgiveness, and acceptance. These experiences are treated as therapeutically important, not merely incidental.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupportive-expressive psychedelic psychotherapy
Therapists must be able to help participants confront, tolerate, and work through intense experiences rather than prematurely suppress them. The method emphasizes support, reassurance, emotional processing, and integration of meaningful material.
2 care stages · 1 guidelines · 0 courses · 0 providers
LSDTiming and calibration of interventions
A key applied skill is knowing when to remain silently present, when to inquire, and when to offer more active guidance. Effective work depends on moment-to-moment attunement to verbal, nonverbal, historical, and pharmacological cues.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAUnderstand LSD dosing framework used in therapy
The intervention involved two dosing sessions with either low-dose or high-dose LSD, implying facilitators need knowledge of session-based LSD administration frameworks. This includes understanding that psychotherapy support is paired with specified dosing regimens.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDUse self-directed enquiry
Help participants direct attention to their own present-moment internal experience and explore it from multiple perspectives. This is practiced in preparation and used to support participants if challenging material emerges during dosing.
3 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinObserving and holding space without reacting
Learners are expected to develop the ability to witness clients and processes calmly, without overreacting or trying to control the experience. The course explicitly frames this as foundational to practitioner development.
4 care stages · 0 guidelines · 1 courses · 1 providers
Supervised experiential practice
A defining feature of the training is hands-on experiential practice in both non-substance and substance-based modalities under supervision. Learners practice patient and therapist roles, facilitating and undergoing sessions in a structured learning context.
5 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinWorking within legal and approved site structures
The practicum requires placements at pre-approved sites and emphasizes legal and ethical standards. Learners are exposed to different settings, including clinical, retreat, and harm reduction organizations.
3 care stages · 0 guidelines · 1 courses · 1 providers
Other categories
Explore the rest of the competency taxonomy.